Chopra, Slaughter: FTC approval of Pfizer/Mylan may invite collusion
Both Democratic members of the Federal Trade Commission have warned that the conditional approval of Pfizer’s sale of its Upjohn division to Mylan may make it easier for companies in the pharmaceutical industry to coordinate prices.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10